Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast CancerLuca Gianni, Gianni Bonadonna, Dolores Sabadell et al.|Journal of Clinical Oncology|2009Cited by 216
Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationFlavio Crippa, Emilio Bombardieri, Ettore Seregni et al.|European Journal of Nuclear Medicine and Molecular Imaging|1998Cited by 186
Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative TherapyLuca Gianni, José Baselga, W. Eiermann et al.|Clinical Cancer Research|2005Cited by 165
A review of the “OMICS” for management of patients with obstructive sleep apnoeaLuana Conte, Michele De Benedetto, Marco Greco et al.|Acta Otorhinolaryngologica Italica|2020Cited by 19